Piotr Ponikowski

机构：University of Wrocław, Indiana University Hospital, John Radcliffe Hospital, University Medical Center, Fraunhofer Institute for Microengineering and Microsystems, Wroclaw Medical University, Heart Foundation, Uczelnia Korczaka – Akademia Nauk Stosowanych, Silesian Center for Heart Disease, Central Clinical Hospital, University of Business in Wrocław · ORCID：0000-0002-3391-7064

发表论文 1417 篇 · 总被引 261588 次 · h-index 181

代表论文

• Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial (2025 · The Lancet · 被引 77)
• Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials (2025 · The Lancet · 被引 39)
• Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial (2025 · European Heart Journal · 被引 19)
• Sodium Chloride Versus Glucose Solute as a Volume Replacement Therapy for More Effective Decongestion in Acute Heart Failure (SOLVRED-AHF): A Prospective, Randomized, Mechanistic Study (2025 · European Journal of Heart Failure · 被引 18)
• SGLT2 Inhibitors for the Prevention and Treatment of Heart Failure: A Scientific Statement of the HFA and the HFAI (2025 · ESC Heart Failure · 被引 15)
• Evaluating the Risk of Hypophosphatemia with Ferric Carboxymaltose and the Recommended Approaches for Management: A Consensus Statement (2025 · Journal of Clinical Medicine · 被引 13)